FOR RESEARCH & CLINICAL TRIALS
RESP® Biosensor
Continuous cough monitoring and additional endpoints for stronger evidence in life sciences & research
FDA 510(k) Class II | CE Mark | HIPAA Compliant
Research Solution Overview
The RESP® Biosensor System is an FDA-cleared, high-fidelity technology for objectively monitoring cough and other respiratory metrics alongside patient-reported outcomes.
- Patient-Friendly: A wireless, discreet design that respects patient comfort and lifestyle.
- Comprehensive Metrics: Collects a robust combination of respiratory measurements to provide multiple insights all in one device
- Validated Reporting: Our qualified and trained annotation team ensures reporting meets endpoint requirements.
RESP® Biosensor Measures
Cough Monitoring
24-Hour Cough Frequency, Intensity* and Bouts
Lung Sounds
Wheeze, Rhonchi, Crackles
Additional Insights*
Respiratory Rate, Heart Rate, Chest Excursions, Activity Levels, Sleep/Wake
*For investigational use only
Trusted By
Metrics-at-a-Glance
1M+
Lung Sounds Captured
30M+
Breaths Captured
32
Countries
35
2
1
Why the RESP® Biosensor System?
Privacy & Security
Incorporates end-to-end encryption and speech obfuscation to preserve patient privacy.
Accelerated Data Turnaround
Cloud-based syncs from paired mobile phone allow for remote data uploads, streamlining data reporting and overread process.
High Fidelity Device
FDA 510(k) cleared device trusted for clinical trials, with the ability to distinguish subject coughs from external coughs.
Patient-Friendly
Wireless, lightweight biosensor secured by a gentle and breathable adhesive.
Comprehensive Insights
Collects a robust combination of data to effectively measure cough severity and provide a more complete respiratory picture.
*For investigational use only
More Than a Cough Monitor
Using a combination of audio and motion data, the RESP Biosensor unlocks valuable insight across multiple indications, offering a more complete picture of subjects’ respiratory status and health-related quality of life alongside PROs.
| Cough | Wheeze | Crackles | Respiratory Rate* | Heart Rate* | Activity Level* | Orientation* | |
| Chronic Cough | |||||||
| IPF | |||||||
| Bronchitis | |||||||
| COPD | |||||||
| Asthma | |||||||
| RSV | |||||||
| Covid-19 | |||||||
| Heart Failure |
- Chronic Cough
- IPF
- Bronchitis
- COPD
- Asthma
- RSV
- Covid-19
- Heart Failure
*For investigational use only
Flexible Reporting—Automated or Human Annotation
- Strados Labs’ trained and qualified annotation team identifies and counts cough and lung sound events from subject recordings to meet clinical trial endpoint requirements.
- Machine learning algorithms* for automated cough detection are also available for applications such as high-volume screening or exploratory endpoints.
*Machine learning algorithms not FDA-cleared
Visual spectrograms of lung sound events facilitate overread for trained annotators
Cough
Wheeze
Crackles
Patient-Friendly Form Factor
- The RESP Biosensor offers an unobtrusive, wireless form factor to reduce patient burden in clinical trials.
- 3M Tegaderm dressing, gentle and breathable, is used to adhere biosensor to chest
- Discreet design helps ensure patients behave naturally, capturing authentic symptom data that mirrors real-life conditions and minimizes the Hawthorne effect.
Publications
View our clinical validation, whitepapers and case studies
Poster Presentation, American Thoracic Society, 2022
Poster Presentation, American Cough Conference, 2023
Poster Presentation, American Thoracic Society, 2022
Talk to our Team
Explore using the RESP® Biosensor in your next study